| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/13/1995 | WO1995018630A1 A method to produce a substance to inhibit cell penetration, and a contraceptive to prevent conception, and a thrombus, prostate and aids vaccine and medicine |
| 07/13/1995 | WO1995011919A3 Recombinant pilc proteins, process for producing them and their use |
| 07/13/1995 | WO1995008631A3 Target antigens of transmission blocking antibodies for malaria parasites |
| 07/13/1995 | WO1995006122A3 Recombinant alternaria alternata allergenes |
| 07/13/1995 | WO1995006121A3 Recombinant cladosporium herbarum allergens |
| 07/13/1995 | CA2180662A1 New polyaminocarboxylate chelators |
| 07/13/1995 | CA2180551A1 Herpesvirus replication defective mutants |
| 07/13/1995 | CA2180531A1 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells |
| 07/13/1995 | CA2180427A1 Nucleotide and amino acid sequences of a t. pallidum rare outer membrane protein |
| 07/12/1995 | EP0662612A1 A method of using novel antibodies for the detection of benign and malignant tumors |
| 07/12/1995 | EP0662150A1 Maspin, a novel serpin with tumor suppressing activity |
| 07/12/1995 | EP0662148A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
| 07/12/1995 | EP0662146A1 Dorsal tissue affecting factor and compositions |
| 07/12/1995 | EP0662139A1 Recombinant retroviral vector against felv and/or fiv |
| 07/12/1995 | EP0662133A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 07/12/1995 | EP0662132A1 Self-assembling recombinant papillomavirus capsid proteins |
| 07/12/1995 | EP0662130A1 A method of producing hepatocyte growth factor and a cell line |
| 07/12/1995 | EP0662129A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 07/12/1995 | EP0662125A1 Delivery of proteins by intermembrane transfer for preaccommodation of xenogeneic organ transplants and other purposes |
| 07/12/1995 | EP0662092A1 Activity-dependent neurotrophic factor |
| 07/12/1995 | EP0662088A1 Inhibitor of collagen-stimulated platelet aggregation |
| 07/12/1995 | EP0662086A1 Protein l and hybrid proteins thereof |
| 07/12/1995 | EP0662085A1 Peptide showing cross-reactivity with the anti-hepatitis b surface antigen antiserum |
| 07/12/1995 | EP0662083A1 Synthetic peptide vaccine for chlamydia trachomatis |
| 07/12/1995 | EP0662082A1 Novel branched hybrid and cluster peptides effective in diagnosing and detecting non-a, non-b hepatitis |
| 07/12/1995 | EP0662077A1 Cd27 ligand |
| 07/12/1995 | EP0662000A1 Antigen-carrying microparticles and their use in the induction of humoral or cellular responses |
| 07/12/1995 | EP0661999A1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 07/12/1995 | EP0661998A1 Therapeutic agent from mycobacterium vaccae and its use against hiv infection |
| 07/12/1995 | EP0661997A1 Method of increasing egg production in avian species by active immunization against vasoactive intestinal peptide |
| 07/12/1995 | EP0661996A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses |
| 07/12/1995 | EP0661985A1 Cd8 binding domain peptides |
| 07/12/1995 | EP0661980A1 Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients |
| 07/12/1995 | EP0390798B1 Method and compositions relating to regression-associated antigens |
| 07/12/1995 | EP0316319B1 Production and use of non-glycosylated IL-6 |
| 07/12/1995 | CN1104915A Compounded polyvalent staphylococcin injection |
| 07/11/1995 | US5432155 Conotoxins I |
| 07/11/1995 | US5431881 Treatment of hair loss and dermatological problems |
| 07/11/1995 | CA1336308C Polysaccharide-protein conjugates |
| 07/11/1995 | CA1336270C Recombinant mycobacterial vaccine |
| 07/11/1995 | CA1336262C Mycoplasma vaccine |
| 07/06/1995 | WO1995018381A1 Immunoassays for prostate specific antigen |
| 07/06/1995 | WO1995018231A1 Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection |
| 07/06/1995 | WO1995018226A1 Tuberous sclerosis 2 gene and uses thereof |
| 07/06/1995 | WO1995018225A1 Polycystic kidney disease 1 gene and uses thereof |
| 07/06/1995 | WO1995018221A1 Gene coding for adseverins |
| 07/06/1995 | WO1995018155A1 Method of producing a concentrate of anti-d immunoglobulin g and pharmaceutical preparation which contains it |
| 07/06/1995 | WO1995018148A1 T-cell epitopes |
| 07/06/1995 | WO1995018145A1 Conjugates of human mucin and a carbohydrate polymer and their use in cancer treatment |
| 07/06/1995 | WO1995017907A1 Methods and compositions for inhibiting thrombogenesis |
| 07/06/1995 | WO1995017906A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 07/06/1995 | WO1995017905A1 Ileal bile acid transporter compositions and methods |
| 07/06/1995 | WO1995016038A3 Humanized antibodies and uses thereof |
| 07/06/1995 | WO1995012682A3 Viral vector with bovine viral diarrhea virus (bvdv) antigens |
| 07/06/1995 | CA2180359A1 Ileal bile acid transporter compositions and methods |
| 07/06/1995 | CA2180287A1 T-cell epitopes |
| 07/06/1995 | CA2180140A1 Methods and compositions for inhibiting thrombogenesis |
| 07/06/1995 | CA2179639A1 Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection |
| 07/05/1995 | EP0661295A1 Cedar pollen protein and uses thereof |
| 07/05/1995 | EP0661294A1 Cedar pollen protein and uses thereof |
| 07/05/1995 | EP0661267A1 Chelating agent for attaching metal ions to proteins |
| 07/05/1995 | EP0661061A2 Vaccine composition for eliciting an immune response against N-glycolylated gangliosides and its use for cancer treatment |
| 07/05/1995 | EP0661060A2 Highly concentrated immunoglobulin composition and method to prepare it |
| 07/05/1995 | EP0661059A2 An intranasal bovine trivalent vaccine containing modified live IBRV, PI3V and BRSV |
| 07/05/1995 | EP0660721A1 Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells |
| 07/05/1995 | CN1029239C Production of hepatitis A vaccine |
| 07/04/1995 | US5430135 DNA sequence encoding a cynomolgus monkey hepatitis A virus capsid protein |
| 07/04/1995 | US5429928 Measuring ouabain level using an antibody having binding specificity to ouabain |
| 07/04/1995 | US5429818 Immunology by injection |
| 07/04/1995 | US5429746 Antibody purification |
| 07/04/1995 | CA1336171C Cytokeratin tumor markers and assays for their detection |
| 07/04/1995 | CA1336166C Further improvements relating to drug delivery systems |
| 06/30/1995 | CA2136677A1 Method of intranasally administering to bovines a trivalent vaccine containing modified live ibrv, pl3v and brsv |
| 06/29/1995 | WO1995017677A1 Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms |
| 06/29/1995 | WO1995017511A2 Mycobacteria virulence factors and a method for their identification |
| 06/29/1995 | WO1995017503A1 Thermostable varicella zoster virus |
| 06/29/1995 | WO1995017502A1 Monoclonal antibodies to hepatitis e virus and methods for using same |
| 06/29/1995 | WO1995017416A1 Dna encoding the wnt-x growth factor |
| 06/29/1995 | WO1995017412A1 NOVEL HUMAN β2 INTEGRIN ALPHA SUBUNIT |
| 06/29/1995 | WO1995017211A1 Non-toxic mucosal adjuvant |
| 06/29/1995 | WO1995017210A1 Vaccines |
| 06/29/1995 | WO1995017209A1 Vaccines |
| 06/29/1995 | WO1995017208A1 'prophylaxis of allergic disease' |
| 06/29/1995 | WO1995017202A1 Method of preventing or treating disease characterized by neoplastic cells expressing cd40 |
| 06/29/1995 | WO1995017200A1 METHODS FOR THE PRODUCTION AND USE OF ANTI-IDIOTYPIC ANTIBODIES USING HUMAN Ig EXPRESSING TRANSGENIC ANIMALS |
| 06/29/1995 | WO1995017198A1 A novel tumor suppressor gene |
| 06/29/1995 | WO1995017167A1 Immunological response potentiation process |
| 06/29/1995 | CA2179772A1 Mycobacteria virulence factors and a method for their identification |
| 06/29/1995 | CA2179494A1 Monoclonal antibodies to hepatitis e virus and methods for using same |
| 06/29/1995 | CA2179196A1 Method of preventing or treating disease characterized by neoplastic cells expressing cd40 |
| 06/29/1995 | CA2179170A1 Prophylaxis of allergic disease |
| 06/29/1995 | CA2179153A1 Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms |
| 06/29/1995 | CA2178745A1 A novel tumor suppressor gene |
| 06/29/1995 | CA2177061A1 Dna encoding the wnt-x growth factor |
| 06/29/1995 | CA2177060A1 Thermostable varicella zoster virus |
| 06/29/1995 | CA2156718A1 Immunological response potentiation process |
| 06/29/1995 | CA2156622A1 Novel human .beta.2 integrin alpha subunit |
| 06/29/1995 | CA2138853A1 Highly concentrated immunoglobulin preparation and method for its production |
| 06/28/1995 | EP0659885A1 Vaccine against viruses associated with antibody-dependent-enhancement of viral infectivity |
| 06/28/1995 | EP0659879A2 Control of pH during bordetella growth |